• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Tumor Cell Lines

HL-60

  • BSL

    1

  • 59
HL-60 is a promyelocytic cell line derived by S.J. Collins, et al. Peripheral blood leukocytes were obtained by leukopheresis from a 36-year-old Caucasian female with acute promyelocytic leukemia.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options

HL-60 is a human leukemic cell line originated from a 36-year-old female diagnosed with acute promyelocytic leukemia. Notably, these cells possess the remarkable ability to differentiate into mature white blood cell types, including neutrophils and monocytes, when exposed to compounds such as dimethyl sulfoxide (DMSO) or retinoic acid. Characterized by a doubling time of approximately 36 to 48 hours, HL-60 cells exhibit heterogeneity in size, ranging from 9-25μm. They belong to the myeloblastic or promyelocytic category and display tumorigenic properties when implanted in nude mice, forming subcutaneous myeloid tumors. Gene expression analysis reveals the presence of the tumor necrosis factor (TNF) gene, specifically TNF-alpha, upon stimulation with phorbol myristic acid, as well as the myc+ gene. Notably, HL-60 cells harbor an amplified c-myc proto-oncogene, with high c-myc mRNA levels in undifferentiated cells that rapidly decline following induction of differentiation.

 

Why choose HL-60 from AcceGen?

HL-60 cells from AcceGen are characterized by their exceptional quality and viability. They are guaranteed to be sterile, tested negative for bacteria, fungi, and mycoplasma contamination, ensuring the utmost reliability in experiments. Identity verification is performed through STR analysis, and these cells undergo rigorous quality control to maintain their integrity and consistency.

Product Code

HL 60; HL.60 HL60; Human Leukemia-60

Species

Human

Cat.No

ABC-TC0389

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Myeloblastic

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Promyelocytic Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Leukemia Cell Lines

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

View More
View Product Image

Application

  • FOR RESEARCH USE ONLY

  • HL-60 cells play a crucial role in various aspects of biological science, serving as a versatile tool for a range of applications. They are instrumental in evaluating the efficacy of chemotherapy drugs and identifying vaccine targets. Additionally, these cells are invaluable in studying critical processes such as cell differentiation, phagocytosis, and calcium influx. Furthermore, HL-60 cells serve as an essential model system for investigating the cellular and molecular mechanisms involved in the proliferation and differentiation of leukemic cells. They are also utilized in the production of extracellular vesicles (EVs), making them a cornerstone in scientific research across multiple domains.

Inquiring HL-60

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

  • Blood (158)
  • Human (1729)
  • Leukemia (126)
  • Lymphoblast (57)
AcceGen Scroll Top Button